secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenwich LifeSciences, Inc. (GLSI)
CIK:        0001799788
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001493152-24-024035
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Greenwich LifeSciences raises ~$2.5M in private placement with CEO at $14.30/share
--------------------------------------------------------------------------------

- CEO Snehal Patel purchased 174,825 shares at $14.30 (June 12 closing price) for ~$2.5M gross proceeds.
- Shares are restricted securities, no registration rights; closing expected June 18, 2024.
- Net proceeds to be used for clinical development and working capital.
- Private placement is exempt under Section 4(a)(2) and Rule 506 of Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799788/000149315224024035/0001493152-24-024035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799788/000149315224024035/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer